MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » How is the coronavirus affecting medtech events?

How is the coronavirus affecting medtech events?

By

medical device events closed coronavirus
[Image from Unsplash]
The coronavirus (COVID-19) outbreak has swept the globe and made a huge impact in the medtech space — especially when it comes to the events that provide a crucial networking and innovation-sharing function.

The March 5 cancellation of the Healthcare Information and Management Systems Society (HIMSS) 2020 Global Health Conference & Exhibition was one of the first examples of the reaction to the outbreak and the domino effect it may have. Conversely, Biogen (NSDQ:BIIB) hosted a company meeting the same week in which up to 175 people could have been exposed to the virus after three employees who had tested positive for COVID-19 were in attendance, raising concerns over the potential knock-on effect of meetings, conferences, shows and more.

Here at WTWH Media’s MassDevice, we’ve started a running tally of canceled medtech and medical device events. Here is our updated list of canceled events:

  • HRS2020

    • The 2020 Heart Rhythm Scientific sessions scheduled for May 6-9 in San Diego have been canceled as a result of the coronavirus.
    • In lieu of in-person meetings, HRS intends to offer digital programs on its Heart Rhythm 365 online learning platform. They will be available on May 6. The platform will include abstract presentations and webinars in place of the expected abstracts that were planned for the event.
    • HRS2021 will take place in Boston from May 19-22, 2021.

  • EAS Congress

    • The European Atherosclerosis Society announced that it is moving its EAS 2020 conference in Geneva to new dates from Oct. 4-7, 2020.
    • EAS maintained in an announcement that it will proceed with the originally planned programming in the same city as previously established.
    • The society added that it will have more information in the coming days as it can provide more details regarding the changed dates and updated event.

  • AAOS

    • The American Academy of Orthopedic Surgeons announced that it is canceling its annual meeting, scheduled for March 24-28 at the Orange County Convention Center in Orlando, Fla.
    • The academy expected the meeting to host 479 presentations in 250,000 net square feet of exhibit space with 27,000 attendees from around the world.
    • AAOS said it plans to share details soon on how it will “work to bring the substance and spirit” of the meeting to those who had planned to participate.

  • ACC.20/WCC

    • The joint meeting of the American College of Cardiology and World Congress of Cardiology was scheduled for March 28-30 in Chicago. The ACC announced that it will not be held amid worries stemming from coronavirus.
    • More than 18,000 attendees from 108 countries were expected to attend.
    • “With an ever-increasing number of ACC members on the front lines of preparing and reacting to the COVID-19 outbreak, we believe it is in the best interest of everyone to cancel the meeting and ensure our members are able to do what they do best—help and heal,” ACC president Dr. Richard Kovacs said in a prepared statement. “This is a first for us. We have never not held an Annual Scientific Session live and in-person in the last 69 years.”
    • Kovacs noted that there are virtual presentations in the works as the ACC seeks to recognize award winners and deliver some information intended to be shared at the meeting. The ACC plans to share more information regarding refunds and options in the coming days.

  • AdvanSE Life Sciences Conference

    • Southeast Life Sciences announced that it intends to hold its inaugural AdvanSE Life Sciences Conference as planned from May 26-28 at the Wild Dunes Resort in Isle of Palms, S.C.
    • In a news release, Southeast Life Sciences told potential attendees that it plans to monitor the state, regional, national and international responses and recommendations and to quickly communicate any decision to postpone the event.

  • BIOMEDevice

    • The BIOMEDevice Boston Design & Manufacturing event has been moved to Sept. 16-17.
    • Those who have registered will have their attendee registration automatically transferred to the rescheduled date and no action is needed at this time, according to a release.
    • Anyone who booked hotel rooms in the event block will receive information regarding rescheduling dates and the process of canceling the existing room and reserving a new one.
    • Updates will be posted on the event website as they become available.

  • Design of Medical Devices 2020

    • The University of Minnesota canceled its Design of Medical Devices 2020 conference due to the coronavirus outbreak.
    • The event had been scheduled for April 6-9 in Minneapolis.
    • According to a news release, planners are in the process of setting up a one-day DMD 2020 event later this year so that artificial intelligence and medical devices emerging technology forums may be held, along with other topics. More information on that is expected to come soon.
    • Those who registered for the event will receive information about refund options. DMD 2021 is set for April 12-15 next year.

  • DeviceTalks

    • Registration remains open for DeviceTalks Minnesota (June 1-2) and DeviceTalks West (June 23-23).
    • Conference organizer WTWH Media (which also owns MassDevice and MDO) has instituted a policy to ensure sponsors and attendees are financially protected in the event of a cancellation.
    • WTWH Media will monitor the situation and decide if the conferences should be postponed. The decision will be made in April.
    • DeviceTalks Boston (Sept. 24-25) is proceeding as scheduled. That will take place at the Hynes Convention Center alongside the Robotics Expo and Healthcare Robotics Engineering Forum.
    • Any questions or comments can be sent to Tom Salemi, editorial director, tsalemi@wtwhmedia.com

  • ECR 2020

    • The European Society of Radiology postponed its annual ECR congress for July 15-19 in Vienna, Austria. The event was previously scheduled to take place from March 11-15.
    • Registration fees and online services remain in place for the new date and registration remains open.

  • ESC Acute Cardiovascular Care conference

    • On March 4, the European Society of Cardiology called off its Acute Cardiovascular Care conference, scheduled for March 7-9 in Athens. At the time of cancellation, the CDC had confirmed eight cases of coronavirus in Greece.
    • ESC was expecting more than 1,000 participants from over 70 countries, and said it will be looking into the possibility of rescheduling for a later date.
    • “Your health and safety are of the greatest priority to us,” Acute Cardiovascular Care Association president Susanna Price said in a news release. “You have a vital role to play throughout the year but especially now, during the spread of the coronavirus. Most of the reported deaths from COVID-19 have been in patients with underlying cardiovascular disease.”

  • MDIC

    • The Medical Device Innovation Consortium postponed its Patient Engagement Forum scheduled for March 26 in Washington, D.C., citing advisories and restrictions imposed by the CDC and WHO.
    • MDIC said it is monitoring updates and recommendations and will notify registered attendees of a new date once it is confirmed.

Large gathering are also temporarily banned in Silicon Valley, The Hill reports.

This story originally ran on Monday, March 9, 2019. We’ll keep this updated with more events impacted by the coronavirus outbreak.

In case you missed it

RSS From Medical Design & Outsourcing

  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]